Paroxysmal Nocturnal Hemoglobinuria clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Crovalimab Versus Eculizumab In Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
Sorry, in progress, not accepting new patients
A study designed to evaluate the safety of crovalimab with eculizumab in participants with PNH currently treated with complement inhibitors. This study will enroll approximately 190 participants.
Anaheim, California and other locations
Last updated: